TITLE

FDA GRANTS 'APPROVABLE' FOR TEVA'S ANDA FOR GABAPENTIN

PUB. DATE
September 2002
SOURCE
Worldwide Biotech;Sep2002, Vol. 14 Issue 9, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Deals with the approval received by Teva Pharmaceutical Industries Ltd. from the U.S. Food and Drug Administration for its generic equivalent of the anticonvulsant drug of Pfizer.
ACCESSION #
7248247

 

Related Articles

  • FDA APPROVES TEVA'S ANDA TO MARKET GENERIC VERSION OF ZOCOR.  // Worldwide Biotech;Aug2006, Vol. 18 Issue 8, p1 

    Reports on the approval granted by the U.S. Food and Drug Administration for Teva Pharmaceutical Industries' Abbreviated New Drug Application to market its generic version of Merck's Zocor Tablets. Indication of Teva's Simvastatin Tablets; Annual brand product sales in the U.S.

  • Pharma: Other News To Note.  // BioWorld Today;4/6/2012, Vol. 23 Issue 67, p7 

    The article reports on the 180-day exclusivity granted by the U.S. Food and Drug Administration (FDA) to a drug application filed by Teva Pharmaceutical Industries Ltd. for its wakefulness drug Provigil.

  • Complex Biologies: The View from Teva. Conner, Jill B. // Pharmaceutical Executive;Sep2011, Vol. 31 Issue 9, p26 

    The article presents the author's views on work areas concerning biosimilar drugs, that need to be considered by the industry and regulators in the U.S. The author states that the approval pathway for follow-on biologies and non-biologic complex drugs (NBCDs) should be different from...

  • Teva Pharmaceuticals USA. Rankin, Ken // Drug Store News;8/18/97, Vol. 19 Issue 13, pCP16 

    Profiles Kulpsville, Pennsylvania-based generic drug company Teva Pharmaceutical Industries Ltd. Contact information; Financial performance; Company history; Business profile.

  • Teva markets some of top generics.  // Drug Store News;8/18/97, Vol. 19 Issue 13, pCP54 

    Reports on developments related to Teva Pharmaceutical Industries Ltd. Drugs marketed; Business operations in the United States; Company profile.

  • Focusing on new products, partnering.  // Drug Store News;2/16/98, Vol. 20 Issue 3, pCP12 

    Profiles Sellersville, Pennsylvania-based Teva Pharmaceuticals Industries Ltd. New product strategy by the company for 1998; Partnerships being planned by the company; Comment by Bill Fletcher, chief executive officer of the company.

  • Pipeline.  // Medical Marketing & Media;Aug2008, Vol. 43 Issue 8, p12 

    The article offers news briefs related to the U.S. Food and Drug Administration (FDA). TEVA Pharmaceuticals secured FDA's approval for its generic versions of Risperdal tablets. The Aciphex from Esai Ltd. won FDA approval for the short-term treatment of GERD in adolescents over 12 years of age....

  • TEVA GETS FIRST FDA APPROVAL OF KETOCONAZOLE 2% CREAM.  // Worldwide Biotech;Jun2000, Vol. 12 Issue 6, p7 

    Reports that Teva Pharmaceutical Industries Ltd. has received from the United States Food and Drug Administration an approval to manufacture and market Ketoconazole 2% Cream.

  • Teva Pharmaceutical slammer dunk. Goldgaber, Arthur; Allaux, Jean-Francois // Financial World;4/15/97, Vol. 166 Issue 4, p26 

    Reports about the prospects of investing in Teva Pharmaceutical Industries, a company based in Petach Tikva, Israel. Introduction of Copaxone in the market; Anticipated increase in Teva's sales due to Copaxone and the launching of generic drugs; Confidence of Bennett Zimmerman and investors in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics